Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Safety and efficacy of reduced fingolimod dosage treatment.
The immune response in the CNS in Theiler's virus induced demyelinating disease switches from an early adaptive response to a chronic innate-like response.
Causes of upregulation of glycolysis in lymphocytes upon stimulation. A comparison with other cell types.
Sequencing the immunopathologic heterogeneity in multiple sclerosis.
The role of MRI in the evaluation of secondary progressive multiple sclerosis.
Increased S-nitrosothiols are associated with spinal cord injury in multiple sclerosis.
[Quality of life in multiple sclerosis--association with clinical features, fatigue and depressive syndrome].
Genetic burden in multiple sclerosis families.
Effects of amisulpride and aripiprazole on progressive-ratio schedule performance: comparison with clozapine and haloperidol.
Hydration status substantially affects chronic cerebrospinal venous insufficiency assessments.
Microglial nodules in early multiple sclerosis white matter are associated with degenerating axons.
Chronic cerebrospinal venous insufficiency in multiple sclerosis: a highly prevalent age-dependent phenomenon.
Pharmacology of the sphingosine-1-phosphate signalling system.
Timing of cigarette smoking as a risk factor for multiple sclerosis.
Intractable Vomiting Antecedent to Optic Neuritis: An Early Clinical Clue to Neuromyelitis Optica.
Vitamin D as a protective factor in multiple sclerosis.
Signaling mechanisms regulating myelination in the central nervous system.
Combining Self-help and Professional Help to Minimize Barriers to Physical Activity in Persons With Multiple Sclerosis: A Trial of the "Blue Prescription" Approach in New Zealand.
Three Distinct Motifs within the C-terminus of ASIC1a Regulate its Surface Trafficking.
Oligodendroglia in cortical multiple sclerosis lesions decrease with disease progression, but regenerate after repeated experimental demyelination.
N-acetylcysteine (NAC) in neurological disorders: mechanisms of action and therapeutic opportunities.
Automated reference region extraction and population-based input function for brain [(11)C]TMSX PET image analyses.
Damping of monocular pendular nystagmus with vibration in a patient with multiple sclerosis.
Impact of anger on the health-related quality of life of multiple sclerosis patients.
Correction: Cerebral Circulation Time is Prolonged and Not Correlated with EDSS in Multiple Sclerosis Patients: A Study Using Digital Subtracted Angiography.
Pages
« first
‹ previous
…
445
446
447
448
449
450
451
452
453
…
next ›
last »